CBD Studies

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

https://www.nejm.org/doi/pdf/10.1056/NEJMoa1611618

 

Grinspoon, M. D. P. (2021, September 24). Cannabidiol (CBD): What we know and what we don't. Harvard Health. Retrieved August 26, 2022, from https://www.health.harvard.edu/blog/cannabidiol-cbd-what-we-know-and-what-we-dont-2018082414476 

 

Malcolm, E. (2019, October 31).  CBD and multiple sclerosis:  what you need to know.  Multiple Sclerosis News Today.  Retrieved March 20, from https://multiplesclerosisnewstoday.com/news-posts/2019/09/20/cbd-oil-and-multiple-sclerosis/

 

Pisanti, S., Malfitano, A.M., Ciaglia, E., Lamberti, A., Ranieri, R., Cuomo, G., . . . Bifulco, M. (2017). Cannabidiol:  State of the art and new challenges for therapeutic applications.  Pharmacology and Therapeutics, 175, 133-150. Retrieved June 1, 2022, from https://pubmed.ncbi.nlm.nih.gov/28232276/ 

 

Rapin, L. (2021, June 23). Cannabidiol use and effectiveness:  real-world evidence from a Canadian medical cannabis clinic.  Journal of Cannabis Research.  Retrieved June 1, 2022, from https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-021-00078-w#Sec2

Reyer, M.  (2022, January 20). Researchers recommend clinical trials for CBD to prevent Covid 19 based on promising animal data.  UChicago Medicine.  Retrieved July 8, 2022, from https://www.uchicagomedicine.org/forefront/research-and-discoveries-articles/researchers-recommend-clinical-trials-for-cbd